Autoimmune diabetes prevention and reversal by anti-CD20 therapy

被引：0
|
作者：
Hu, C. Y. [1 ]
Rodrigue-Pinto, D. [1 ]
Du, W. [1 ]
Ahnja, A. [2 ]
Wong, F. S. [3 ]
Shlonichik, M. [2 ]
Wen, L. [1 ]
机构：
[1] Yale Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT USA
[2] Yale Sch Med, Dept Lab Med, Immunol Sect, New Haven, CT USA
[3] Univ Bristol, Dept Cellular & Mol Med, Bristol BS8 1TH, Avon, England
来源：
ACTA DIABETOLOGICA | 2007年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [21] Intrathecal administration of anti-CD20 in treatment of experimental autoimmune encephalomyelitis
    Lehmann-Horn, K.
    Radelfahr, F.
    Hemmer, B.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 137 - 137
  • [22] Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab)
    Kain, S
    Copeland, TS
    Leahy, MF
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) : 578 - 578
  • [23] Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia
    Kerridge, I
    Hann, I
    Ethel, M
    Potter, M
    Prentice, HG
    INTERNAL MEDICINE JOURNAL, 2003, 33 (11) : 544 - U3
  • [24] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [25] Anti-CD20 therapy delays or prevents recurrent type 1 diabetes in NOD mice
    Hu, Changyun
    Deng, Songyan
    Wong, Susan
    Wen, Li
    CLINICAL IMMUNOLOGY, 2008, 127 : S18 - S18
  • [26] Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy
    Tschudin, Letizia von Laer
    Schwitzgebel, Valerie M.
    von Scheven-Gete, Annette
    Blouin, Jean-Louis
    Hofer, Michael
    Hauschild, Michael
    Ansari, Marc
    Stoppa-Vaucher, Sophie
    Phan-Hug, Franziska
    PEDIATRIC DIABETES, 2015, 16 (02) : 138 - 145
  • [27] Anti-CD20 treatments and the lymphocyte membrane: Pathology for therapy
    Borisch, B
    Semac, I
    Soltermann, A
    Palomba, C
    Hoessli, DC
    VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 85. TAGUNG: PATHOLOGIE FUR DAS 21. JAHRHUNDERT, 2001, 85 : 161 - 166
  • [28] Should anti-CD20 be used as an immune reconstitution therapy?
    Smets, Ide
    Wokke, Beatrijs
    Smolders, Joost
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 308 - 310
  • [29] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
  • [30] Anti-CD20 Treatment Prolongs Syngeneic Islet Graft Survival and Delays the Onset of Recurrent Autoimmune Diabetes
    Hu, Changyun
    Deng, Songyan
    Wong, F. Susan
    Wen, Li
    IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE, 2008, 1150 : 217 - 219
12345